GSPQX has more cash in the bank: 3.94B vs. FBPGX (101M). FBPGX pays higher dividends than GSPQX: FBPGX (2.97) vs GSPQX (0.06). FBPGX was incepted earlier than GSPQX: FBPGX (3 years) vs GSPQX (21 years). GSPQX (1.86) is less costly to investors than FBPGX (1.43). FBPGX is a more actively managed with annual turnover of: 33.00 vs. GSPQX (29.00). FBPGX (1000) and GSPQX (1000) have matching initial minimum investment requirements. FBPGX annual gain was more profitable for investors over the last year : 16.36 vs. GSPQX (13.89).

	FBPGX	GSPQX	FBPGX / GSPQX
Total Expense Ratio	1.26	1.75	72%
Annual Report Gross Expense Ratio	1.43	1.86	77%
Fund Existence	3 years	21 years	-
Gain YTD	20.224	12.651	160%
Front Load	6%	N/A	-
Min. Initial Investment	1000	1000	100%
Min. Initial Investment IRA	N/A	N/A	-
Net Assets	101M	3.94B	3%
Annual Yield % from dividends	2.97	0.06	4,624%
Returns for 1 year	16.36	13.89	118%
Returns for 3 years	36.80	39.77	93%
Returns for 5 years	N/A	27.70	-
Returns for 10 years	N/A	75.02	-

View a ticker or compare two or three

Ask AI

Compare

Interact to see
Advertisement

Interesting Tickers

STOCK / NAME	Price $	Chg $	Chg %
		1 Day
USIO	2.81	0.15	+5.64%
Usio
PRLD	6.63	0.13	+2.00%
Prelude Therapeutics
PMAX	1.26	0.02	+1.61%
Powell Max Limited
BWXT	156.78	0.34	+0.22%
BWX Technologies
SUPN	45.85	-1.60	-3.37%
Supernus Pharmaceuticals